Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine pharmacological conditioning for pain sensitivity in fibromyalgia
2019-004812-73Phase 4Terminated
- Sponsor
- Leiden University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in fibromyalgia (FM) comparing S-ketamine pharmacological conditioning with Placebo pharmacological conditioning (2 arms). Primary endpoint: Change in pressure pain thresholds. Started May 2022; status: terminated.
02
Drugs
esketamine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2019-004812-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004812-73.